This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Co-amoxiclav

Authoring team

Co-amoxiclav is a compound preparation of amoxycillin and the beta-lactamase inhibitor clavulanic acidn(1).. The clavulanic acid protects the amoxycillin from the penicillinases produced by virtually all Staphylococci, 30% of E.coli, a 10% of H.influenzae and many Bacteroides and Klebsiella species (2).

Co-amoxiclav also can be an effective drug for the antimicrobial treatment and prophylaxis of many anaerobic infections (3).

Contra-indications include:

  • penicillin hypersensitivity

The summary of product characteristics should be consulted before prescribing this drug.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.